These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8225695)

  • 41. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
    Lin CC; Huang JF; Tsai LY; Huang YL
    Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
    Torres M; Rodríguez-Serrano F; Rosario DJ; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):69-74. PubMed ID: 16929590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70.
    Bedirli A; Sakrak O; Muhtaroglu S; Soyuer I; Guler I; Riza Erdogan A; Sozuer EM
    J Surg Res; 2004 Nov; 122(1):96-102. PubMed ID: 15522321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress.
    Federico A; Dallio M; DI Fabio G; Zarrelli A; Zappavigna S; Stiuso P; Tuccillo C; Caraglia M; Loguercio C
    In Vivo; 2015; 29(5):569-75. PubMed ID: 26359416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidised derivatives of silybin and their antiradical and antioxidant activity.
    Gazák R; Svobodová A; Psotová J; Sedmera P; Prikrylová V; Walterová D; Kren V
    Bioorg Med Chem; 2004 Nov; 12(21):5677-87. PubMed ID: 15465345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats.
    Pradeep K; Mohan CV; Gobianand K; Karthikeyan S
    Eur J Pharmacol; 2007 Apr; 560(2-3):110-6. PubMed ID: 17300777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016.
    Carini R; Comoglio A; Albano E; Poli G
    Biochem Pharmacol; 1992 May; 43(10):2111-5. PubMed ID: 1599497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silybin-phosphatidylcholine complex. Monograph.
    Altern Med Rev; 2009 Dec; 14(4):385-90. PubMed ID: 20030465
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antioxidant activity of hepatotropic preparations in the treatment of chronic diseases of the liver].
    Loginov AS; Matiushin BN; Sukhareva GV; Tkachev VD
    Ter Arkh; 1988; 60(8):74-7. PubMed ID: 3227482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical indicators and cardiac function tests in chronic alcohol abusers.
    Avşaroglu D; Inal TC; Demir M; Attila G; Acartürk E; Emre Evlice Y; Kayrin L
    Croat Med J; 2005 Apr; 46(2):233-7. PubMed ID: 15849844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serum lipid peroxide levels in chronic hepatitis and its behavior following antioxidant administration].
    Tufănoiu E; Rob I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):333-9. PubMed ID: 2865794
    [No Abstract]   [Full Text] [Related]  

  • 53. [Enzyme activity and dynamics of blood levels of microelements during the complex treatment of chronic liver diseases].
    Neĭko VE
    Vrach Delo; 1985 Jun; (6):61-3. PubMed ID: 4024589
    [No Abstract]   [Full Text] [Related]  

  • 54. Silybin and the liver: from basic research to clinical practice.
    Loguercio C; Festi D
    World J Gastroenterol; 2011 May; 17(18):2288-301. PubMed ID: 21633595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN; Okorokov AN; Fedorov NE; Laktionova AA; Sidorenko LF
    Ter Arkh; 1986; 58(2):76-9. PubMed ID: 3704946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The antagonistic effect of silybin-dihemisuccinate on disorders of phosphatidyl synthesis in the rat liver].
    Schriewer H; Weinhold F; Stöcker K; Rauen HM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():309-11. PubMed ID: 1029194
    [No Abstract]   [Full Text] [Related]  

  • 57. Silybin inhibition of amatoxin uptake in the perfused rat liver.
    Faulstich H; Jahn W; Wieland T
    Arzneimittelforschung; 1980; 30(3):452-4. PubMed ID: 7387753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
    Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of polyunsaturated phosphatidylcholine on immune mediated hepatocyte damage.
    Neuberger J; Hegarty JE; Eddleston AL; Williams R
    Gut; 1983 Aug; 24(8):751-5. PubMed ID: 6873737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ageusia as a secondary manifestation of treatment with D-penicillamine].
    Gutiérrez Fuentes JA; Vázquez Gallego MC; Fernández Remis JE; Arroyo Vicente M; Schüller Pérez A
    Rev Clin Esp; 1984 Feb; 172(3):149-51. PubMed ID: 6718787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.